基于退伍军人人群的衰弱评估及其对脑血管疾病管理的意义
本研究利用退伍军人事务手术质量改进项目数据,对2002至2015年间37,873例无症状颈动脉内膜剥脱术患者进行回顾性分析,采用风险分析指数(RAI)评估衰弱程度。结果显示,衰弱程度越高,术后卒中、心肌梗死、任何并发症及死亡风险越高,住院时间越长,建议将RAI作为无症状颈动脉内膜剥脱术患者风险讨论的筛查工具。
要点
- RAI评估的衰弱与颈动脉内膜剥脱术后卒中、心梗、并发症和死亡风险增加相关。
- 非常衰弱组(RAI≥35)术后死亡风险显著升高(OR 4.14,95%CI 3.00-5.71)。
- 建议使用RAI作为无症状颈动脉内膜剥脱术患者术前风险讨论的筛查工具。
核心结论
- RAI评估的衰弱程度增加与无症状颈动脉内膜剥脱术患者术后不良结局(卒中、心梗、并发症、死亡)风险升高相关。
- 建议将RAI作为筛查工具,用于指导无症状颈动脉内膜剥脱术患者的风险讨论。
研究设计与样本
- 回顾性队列研究,数据来源于退伍军人事务手术质量改进项目(VASQIP),纳入2002至2015年间37,873例无症状颈动脉内膜剥脱术患者。
- 根据RAI将患者分为非衰弱组(RAI<30,82.8%,n=31,362)、衰弱组(RAI 30-34,12.4%,n=4,678)和非常衰弱组(RAI≥35,4.8%,n=1,833)。
- 超过98%(37,266)的患者为男性,平均年龄68.3±8.55岁。
主要发现
- 衰弱与术后卒中、心肌梗死、任何并发症、死亡及住院时间延长相关(P<0.001)。
- 衰弱组和非常衰弱组发生一个或多个并发症的OR分别为1.69(95%CI 1.50-1.90)和2.79(95%CI 2.41-3.24)(P<0.001)。
- 衰弱组和非常衰弱组术后卒中的OR分别为1.33(95%CI 1.06-1.67)和1.57(95%CI 1.14-2.16)。
- 衰弱组和非常衰弱组心肌梗死的OR分别为1.68(95%CI 1.17-2.43)和3.73(95%CI 2.52-5.51)。
- 非常衰弱组死亡的OR为4.14(95%CI 3.00-5.71,P<0.001)。
关键数值与推荐
- RAI分组标准:非衰弱RAI<30,衰弱RAI 30-34,非常衰弱RAI≥35。
- 并发症OR:衰弱组1.69(95%CI 1.50-1.90),非常衰弱组2.79(95%CI 2.41-3.24)。
- 卒中OR:衰弱组1.33(95%CI 1.06-1.67),非常衰弱组1.57(95%CI 1.14-2.16)。
- 心肌梗死OR:衰弱组1.68(95%CI 1.17-2.43),非常衰弱组3.73(95%CI 2.52-5.51)。
- 死亡OR:非常衰弱组4.14(95%CI 3.00-5.71)。
临床怎么用
- 对于无症状颈动脉内膜剥脱术患者,可使用RAI进行术前衰弱筛查,以识别术后并发症和死亡高风险人群。
- RAI评分较高的患者(衰弱或非常衰弱)应与患者充分讨论手术风险,辅助临床决策。
局限性
- 研究为回顾性设计,可能存在选择偏倚和未测量混杂因素。
- 研究对象主要为男性退伍军人,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rapid and objective preoperative assessment of patients undergoing carotid endarterectomy (CEA) remains difficult and variable. The Risk Analysis Index (RAI) is a validated medical record-based assessment of frailty that has been used to predict clinical outcomes for patients undergoing surgical procedures including CEA. We applied RAI to a veteran population following CEA for asymptomatic cerebrovascular disease and examined the factors related to post-operative morbidity and mortality. METHODS: After obtaining IRB approval, Veteran Affairs Surgical Quality Improvement Program data was queried for CEA procedures from 2002 to 2015 for ICD-9 codes indicating asymptomatic patients. RAI was then calculated based on Veteran Affairs Surgical Quality Improvement Program variable medical record extraction. Three groupings of patients were undertaken including non-frail (RAI < 30), frail (RAI 30-34) and very frail (RAI ≥ 35). Chi squared and ANOVA were used to assess cohort differences. Binary logistic regression was used to evaluate predictors of post-operative stroke, myocardial infarction (MI), any complication, and death. RESULTS: Between 2002 and 2015, 37,873 asymptomatic patients underwent CEA. Over 98% (37,266) of the patients were male with an average age of 68.3 ± 8.55 years. The cohorts contained 82.8% (n = 31,362), 12.4% (n = 4,678), and 4.8% (n = 1,833) for the non-frail, frail and very frail groups respectively. Frailty was associated with increased rates of post-operative stroke, MI, any complication, death, and longer hospital length of stay (P< 0.001). Operative time did not significantly differ between the groups. Increasing frailty was associated with having one or more complications (OR 1.69, 95% CI 1.50-1.90 for frail and OR 2.79, 95% CI 2.41-3.24 for very frail, (P< 0.001), post-operative stroke in frail (OR 1.33 95% CI 1.06-1.67) and very frail (OR 1.57 1 95% CI 1.14-2.16) patients, and MI in both frail (OR 1.68, CI 1.17-2.43) and very frail (OR 3.73, CI 2.52-5.51) patients. Frailty was also significantly associated with death with in very frail patients (OR 4.14, 95% CI 3.00-5.71, P< 0.001). CONCLUSION: Increasing frailty as determined by RAI was associated with worse post-operative outcomes in asymptomatic patients undergoing CEA. Higher RAI score cohorts were associated with higher rates of postoperative stroke, MI, complications, and death. We recommend the use of this frailty index as a screening tool to guide risk discussions with asymptomatic patients undergoing CEA.
引用
- Boyd S, Tse W, Lavingia K, et al. Frailty Measurement and Implications for Cerebrovascular Disease Management in a Veteran Based Population. Ann Vasc Surg. 2021. PMID: 34004323. doi:10.1016/j.avsg.2021.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。